Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor

NCT00412061 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

429

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoid Tumor
Malignant Carcinoid Syndrome

Interventions

DRUG: Octreotide
DRUG: Placebo
DRUG: Everolimus

Sponsor

Novartis Pharmaceuticals